Annual Total Liabilities
$594.21 M
+$3.86 M+0.65%
31 December 2023
Summary:
Apellis Pharmaceuticals annual total liabilities is currently $594.21 million, with the most recent change of +$3.86 million (+0.65%) on 31 December 2023. During the last 3 years, it has fallen by -$161.80 million (-21.40%). APLS annual total liabilities is now -21.40% below its all-time high of $756.01 million, reached on 31 December 2020.APLS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$664.75 M
+$24.59 M+3.84%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly total liabilities is currently $664.75 million, with the most recent change of +$24.59 million (+3.84%) on 30 September 2024. Over the past year, it has increased by +$78.80 million (+13.45%). APLS quarterly total liabilities is now -21.00% below its all-time high of $841.40 million, reached on 30 June 2021.APLS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.7% | +13.4% |
| 3 y3 years | -21.4% | +14.0% |
| 5 y5 years | +1296.1% | +103.4% |
APLS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.4% | +0.7% | -2.8% | +17.6% |
| 5 y | 5 years | -21.4% | +1296.1% | -21.0% | +103.4% |
| alltime | all time | -21.4% | >+9999.0% | -21.0% | >+9999.0% |
Apellis Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $664.75 M(+3.8%) |
| June 2024 | - | $640.15 M(+13.3%) |
| Mar 2024 | - | $565.25 M(-4.9%) |
| Dec 2023 | $594.21 M(+0.7%) | $594.21 M(+1.4%) |
| Sept 2023 | - | $585.95 M(+2.8%) |
| June 2023 | - | $570.17 M(+0.6%) |
| Mar 2023 | - | $566.75 M(-4.0%) |
| Dec 2022 | $590.35 M(-13.6%) | $590.35 M(+4.4%) |
| Sept 2022 | - | $565.48 M(-15.4%) |
| June 2022 | - | $668.08 M(-2.3%) |
| Mar 2022 | - | $683.62 M(+0.1%) |
| Dec 2021 | $683.10 M(-9.6%) | $683.10 M(+17.2%) |
| Sept 2021 | - | $583.01 M(-30.7%) |
| June 2021 | - | $841.40 M(+10.9%) |
| Mar 2021 | - | $758.47 M(+0.3%) |
| Dec 2020 | $756.01 M | $756.01 M(+14.1%) |
| Sept 2020 | - | $662.49 M(+3.8%) |
| June 2020 | - | $638.04 M(+48.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $429.94 M(+21.1%) |
| Dec 2019 | $355.02 M(+734.1%) | $355.02 M(+8.6%) |
| Sept 2019 | - | $326.80 M(+107.3%) |
| June 2019 | - | $157.62 M(+68.4%) |
| Mar 2019 | - | $93.60 M(+119.9%) |
| Dec 2018 | $42.56 M(+28.2%) | $42.56 M(-1.5%) |
| Sept 2018 | - | $43.19 M(+15.9%) |
| June 2018 | - | $37.27 M(+9.1%) |
| Mar 2018 | - | $34.16 M(+2.9%) |
| Dec 2017 | $33.19 M(+812.1%) | $33.19 M(+378.4%) |
| Sept 2017 | - | $6.94 M(-78.8%) |
| June 2017 | - | $32.69 M(+798.3%) |
| Dec 2016 | $3.64 M(+13.7%) | $3.64 M(+13.7%) |
| Dec 2015 | $3.20 M(+195.9%) | $3.20 M(+20.5%) |
| Sept 2015 | - | $2.66 M(+109.0%) |
| June 2015 | - | $1.27 M(+17.5%) |
| Dec 2014 | $1.08 M(+59.7%) | $1.08 M |
| Dec 2013 | $677.00 K | - |
FAQ
- What is Apellis Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual total liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly total liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total liabilities?
The current annual total liabilities of APLS is $594.21 M
What is the all time high annual total liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total liabilities is $756.01 M
What is Apellis Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, APLS annual total liabilities has changed by +$3.86 M (+0.65%)
What is Apellis Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of APLS is $664.75 M
What is the all time high quarterly total liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total liabilities is $841.40 M
What is Apellis Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, APLS quarterly total liabilities has changed by +$78.80 M (+13.45%)